| Literature DB >> 25077540 |
M J Herold1, L A O'Reilly1, A Lin1, R Srivastava2, M Doerflinger2, P Bouillet1, A Strasser1, H Puthalakath2.
Abstract
Entities:
Mesh:
Substances:
Year: 2014 PMID: 25077540 PMCID: PMC4123084 DOI: 10.1038/cddis.2014.290
Source DB: PubMed Journal: Cell Death Dis Impact factor: 8.469
Figure 1BIM and PUMA do not interact with IRE1α and are dispensable for XBP-1 splicing. (a) HEK 293T cells were transfected with the expression vectors indicated and cell lysates were subjected to straight western blotting (control for expression of ectopically expressed proteins) or immunoprecipitation with FLAG antibody-coupled beads followed by western blotting. Interaction of BIM with LC8 was used as a positive control for co-immunoprecipitation. (b) B cells from mice of the indicated genotypes were activated in culture with various concentrations of LPS for 2–3 days and RNA samples were examined for Xbp-1 splicing. Each mRNA sample consisted of a pool of four mice except for B cells from the BimPuma mice where RNA samples were pooled from three mice. As a positive control for Xbp-1 mRNA splicing, wild-type MEFs were treated for 2.5 h with the ER stressor tunicamycin (100 ng/ml) before harvesting total RNA. The graph on the right shows digital droplet PCR quantification of the spliced form of Xbp-1 in LPS-treated B cells. (c) Quantitation of spliced Xbp-1 in MEFs treated with tunicamycin (100 ng/ml) and expression of its target ERdj4 in MEFs treated with tunicamycin (100 ng/ml) and Q-VD-OPH (25 μM). (d) IgM concentrations in tissue culture supernatants of B cells from the indicated mouse strains were measured by ELISA after these cells had been stimulated with LPS (0.1, 1.0 or 10 μg/ml) for 2 or 3 days. Data represent the mean±S.E.M. of 3–4 mice for each genotype